Oslo, Norway, 20 October 2021 – Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces the appointment of Dr. Erik Digman Wiklund as Chief Executive Officer (CEO). Dr. Wiklund has intimate knowledg... read more

Berlin/Hamburg, 19 October 2021 – The digital therapeutic HelloBetter Stress and Burnout has been permanently approved by the Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by  prescription. It is the world’s f... read more

Oslo, Norway, 19 October 2021 Nordic Nanovector ASA (OSE: NANOV) is pleased to announce that it has entered into a research collaboration with the University of Pennsylvania ("Penn") to generate a CD37-targeting CAR-T cell approach as a potential treatment for patients with B-cell mali... read more

Doctrin – a Swedish healthtech company – has for the last five years proven its ability to transform access to and delivery of care, care continuity, patient experience and efficiency in the Nordics. Doctrin is now going live with its digital platform in the UK to support digitally enabled tran... read more

Dr. Doyle brings more than 20 years of clinical development experience in industry and academia to Aro’s leadership team ​ Philadelphia, PA, October 7, 2021 – Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announc... read more